BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16838325)

  • 1. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
    Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
    Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression changes in a patient presenting nonleukaemic nasal granulocytic sarcoma to acute myelogenous leukaemia using 40 K cDNA microarray.
    Teramoto H; Miwa H; Patel V; Letwin N; Castellone MD; Imai N; Shikami M; Imamura A; Gutkind JS; Nitta M; Lee NH
    Clin Lab Haematol; 2006 Aug; 28(4):262-6. PubMed ID: 16898967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
    Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
    Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in myelodysplastic syndromes.
    Gürkan E; Tanriverdi K; Başlamişli F
    Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
    Qian J; Chen Z; Wang W; Cen J; Xue Y
    Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
    Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
    J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes.
    Tamura H; Dan K; Yokose N; Iwakiri R; Ohta M; Sakamaki H; Tohyama K; Kondo A; Hyodo H; Nakamura K; Yamashita T; Elisseeva OA; Oka Y; Oji Y; Sugiyama H; Ogata K
    Leuk Res; 2010 Aug; 34(8):986-90. PubMed ID: 20031209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
    Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Tiranova SA; Kakaĭ MP; Martynenko LS; Dziavgo LA
    Ter Arkh; 2005; 77(7):22-7. PubMed ID: 16116904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
    Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
    Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
    Bader P; Niemeyer C; Weber G; Coliva T; Rossi V; Kreyenberg H; Gerecke A; Biondi A
    Eur J Haematol; 2004 Jul; 73(1):25-8. PubMed ID: 15182334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
    Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
    Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of gene expression signatures for molecular classification in human leukemia cells.
    Song JH; Kim HJ; Lee CH; Kim SJ; Hwang SY; Kim TS
    Int J Oncol; 2006 Jul; 29(1):57-64. PubMed ID: 16773185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
    Hu Q; Dey AL; Yang Y; Shen Y; Jilani IB; Estey EH; Kantarjian HM; Giles FJ; Albitar M
    Cancer; 2004 May; 100(9):1884-91. PubMed ID: 15112269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome.
    Heinrichs S; Berman JN; Ortiz TM; Kornblau SM; Neuberg DS; Estey EH; Look AT
    Br J Haematol; 2005 Jul; 130(1):83-6. PubMed ID: 15982348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-quantitative study of calcitonin gene methylation in myelodysplastic syndrome.
    Wu S; Xie G; Bai R; Wang Y; Zhu P
    Chin Med J (Engl); 1998 Aug; 111(8):690-3. PubMed ID: 11245020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
    de Melo Campos P; Traina F; da Silva Santos Duarte A; Lorand-Metze I; Costa FF; Saad ST
    Leuk Res; 2007 Jun; 31(6):853-7. PubMed ID: 17270269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.